Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA. (Q39203830)

10 September 2017

title

Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA. (English)

1 reference

10 September 2017

Xianwei Wang

1 reference

10 September 2017

Magomed Khaidakov

1 reference

10 September 2017

Zufeng Ding

1 reference

10 September 2017

Sona Mitra

1 reference

10 September 2017

Jingjun Lu

1 reference

10 September 2017

Shijie Liu

1 reference

10 September 2017

Jawahar L Mehta

1 reference

10 September 2017

publication date

1 December 2012

1 reference

Experimental Biology and Medicine

10 September 2017

published in

1 reference

10 September 2017

volume

237

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

1394-1401

1 reference

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Angiotensin II type 1 and type 2 receptors reciprocally modulate pro-inflammatory/ pro-fibrotic reactions in activated splenic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Upregulation of lectinlike oxidized low-density lipoprotein receptor-1 expression contributes to the vein graft atherosclerosis: modulation by losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012212

21 January 2018

Identifiers

DOI

10.1258/EBM.2012.012212

1 reference

10 September 2017

1 reference